These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Future prospects for use of fibrinolysis inhibitors. Verstraete M J Clin Pathol Suppl (R Coll Pathol); 1980; 14():77-80. PubMed ID: 7000851 [No Abstract] [Full Text] [Related]
23. Protein inhibitors of serine proteinases. Otlewski J; Krowarsch D; Apostoluk W Acta Biochim Pol; 1999; 46(3):531-65. PubMed ID: 10698264 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of plasminogen activator from pig leucocytes. Kopitar M; Stegnar M; Accetto B; Lebez D Thromb Diath Haemorrh; 1974 Mar; 31(1):72-85. PubMed ID: 4545905 [No Abstract] [Full Text] [Related]
25. Inhibitory effects of native and synthetic protease inhibitors on plasma proteases in acute pancreatitis. Takasugi S; Toki N Hiroshima J Med Sci; 1980 Dec; 29(4):189-94. PubMed ID: 7009505 [No Abstract] [Full Text] [Related]
28. Control of proteolysis. Holzer H; Heinrich PC Annu Rev Biochem; 1980; 49():63-91. PubMed ID: 6996569 [No Abstract] [Full Text] [Related]
29. Purification and characterization of a proteinase from Euphausia superba Dana (Antarctic krill). Turkiewicz M; Galas E; Kalinowska H; Romanowska I; Zielińska M Acta Biochim Pol; 1986; 33(2):85-99. PubMed ID: 3532651 [TBL] [Abstract][Full Text] [Related]
30. The structure of thrombin: a janus-headed proteinase. Bode W Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():16-31. PubMed ID: 16673263 [TBL] [Abstract][Full Text] [Related]
31. Cleavage of protein S by a platelet membrane protease. Mitchell CA; Salem HH J Clin Invest; 1987 Feb; 79(2):374-9. PubMed ID: 2948968 [TBL] [Abstract][Full Text] [Related]
32. The many forms and functions of cellular proteinases. Barrett AJ Fed Proc; 1980 Jan; 39(1):9-14. PubMed ID: 6985872 [TBL] [Abstract][Full Text] [Related]
33. [Studies on antiphlogistic effects of fibrinolysin inhibitors]. Feyen H; Nissen H; Rasche H; Hiemeyer V Z Rheumaforsch; 1970; 29(9):276-86. PubMed ID: 4394179 [No Abstract] [Full Text] [Related]
34. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777 [TBL] [Abstract][Full Text] [Related]
35. Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Wang QM; Johnson RB; Sommergruber W; Shepherd TA Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985 [TBL] [Abstract][Full Text] [Related]
36. Chemical specificity and conformational flexibility in proteinase-inhibitor interaction: scaffolds for promiscuous binding. Vishwanath S; Srinivasan N Prog Biophys Mol Biol; 2014; 116(2-3):151-7. PubMed ID: 25151636 [TBL] [Abstract][Full Text] [Related]
39. Structure and function of natural inhibitors as antagonists of proteinase activities. Tschesche H Adv Exp Med Biol; 1984; 167():73-87. PubMed ID: 6369923 [No Abstract] [Full Text] [Related]
40. Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease. Barnum SR Mol Med; 1999 Sep; 5(9):569-82. PubMed ID: 10551898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]